In summary, our data demonstrate increased BTLA expression in CD8 effector T cells and reduced PD-1 expression in all CD3-expressing subpopulations of patients with mild-to-moderate psoriasis, suggesting possible variation in T cell function if these co-inhibitory receptors are engaged. Here, CD8A is linked to psoriasis.